Your session is about to expire
← Back to Search
Educational Strategies for Extubation Outcomes (METEOR Trial)
METEOR Trial Summary
This trial will compare four implementation strategies for ICU care: traditional online education, protocol-directed care, interprofessional education, and a combination of the two. They will test the hypotheses that interprofessional education is superior to traditional online education, and that the benefits of interprofessional education are increased when interprofessional education is paired with a clinical protocol. Additionally, they will test the hypothesis that preventive post-extubation NIV and preventive post-extubation HFNC are both superior to current clinical practice.
METEOR Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMETEOR Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.METEOR Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I was on a breathing machine for more than a day in the ICU.Not applicable.
- Group 1: Interprofessional education about post-extubation HFNC
- Group 2: Interprofessional education plus clinical protocol about post-extubation HFNC
- Group 3: Clinical protocol about post-extubation HFNC
- Group 4: Interprofessional education about risk-stratified post-extubation NIV/HFNC
- Group 5: Clinical protocol about risk-stratified post-extubation NIV/HFNC
- Group 6: Interprofessional education plus clinical protocol about risk-stratified post-extubation NIV/HFNC
- Group 7: Online education about post-extubation HFNC
- Group 8: Usual care
- Group 9: Online education about risk-stratified post-extubation NIV/HFNC
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research program currently enrolling participants?
"Clinicaltrials.gov records indicate that this medical research is not actively enrolling candidates at the moment, despite being initially posted in January 1st 2023 and most recently updated on November 7th 2022. Despite this, 179 other clinical trials are requesting participants right now."
What is the primary objective of this experiment?
"The main goal of this trial, which is to be evaluated over a period of 60 days following the initiation of invasive mechanical ventilation, is to assess the rate of post-extubation noninvasive ventilatory or high flow nasal cannula usage among eligible participants. Secondary endpoints include 28-day ventilator free periods (VFDs) from intubation till 28 days later without reintubation for at least 48 hours; duration between initiating invasive mechanical ventilation and successful extubation with no need for reintubations again within 48 hours; along with hospital stay length ranging from initial intubation until successful discharge"
Share this study with friends
Copy Link
Messenger